Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00KXO
|
|||
| Drug Name |
Ciraparantag
|
|||
| Synonyms |
PER-977; UNII-U2R67KV65Q; Ciraparantag [USAN]; Ciraparantag(PER977); 1438492-26-2; U2R67KV65Q; Ciraparantag (USAN); Aripazine; PER977; PER 977; CHEMBL3544919; SCHEMBL14985871; N1,N1'-(Piperazine-1,4-diylbis(propane-1,3-diyl))bis-L-argininamide; AKOS030526536; CS-5640; Pentanamide, N,N'-(1,4-piperazinediyldi-3,1-propanediyl)bis(2-amino-5-((aminoiminomethyl)amino)-, (2S,2'S)-; HY-18660; D10868
Click to Show/Hide
|
|||
| Indication | Harmful effects of drugs, medicaments or biological substances [ICD-11: NE60] | Phase 2 | [1] | |
| Company |
Perosphere Danbury, CT
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C22H48N12O2
|
|||
| Canonical SMILES |
C1CN(CCN1CCCNC(=O)C(CCCN=C(N)N)N)CCCNC(=O)C(CCCN=C(N)N)N
|
|||
| InChI |
1S/C22H48N12O2/c23-17(5-1-7-31-21(25)26)19(35)29-9-3-11-33-13-15-34(16-14-33)12-4-10-30-20(36)18(24)6-2-8-32-22(27)28/h17-18H,1-16,23-24H2,(H,29,35)(H,30,36)(H4,25,26,31)(H4,27,28,32)/t17-,18-/m0/s1
|
|||
| InChIKey |
HRDUUSCYRPOMSO-ROUUACIJSA-N
|
|||
| CAS Number |
CAS 1438492-26-2
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.